"Bahrain Pharmaceuticals & Healthcare Report Q3 2013" Published
 

13-08-13 11:13 AM

However, annual growth rates of its generic counterpart will be considerably more impressive, despite coming off a very low base, as leading drugs lose their patent protection Headline Expenditure Projections - Pharmaceuticals: BHD100mn (US$266mn ...

Source...